153 related articles for article (PubMed ID: 8981182)
1. Inhibitory and bactericidal activity of rokitamycin against Helicobacter pylori and morphological alterations.
Brenciaglia MI; Fornara AM; Scaltrito MM; Braga PC
J Chemother; 1996 Dec; 8(6):425-31. PubMed ID: 8981182
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of clarithromycin against intracellular Helicobacter pylori.
Piccolomini R; Di Bonaventura G; Picciani C; Laterza F; Vecchiet J; Neri M
Antimicrob Agents Chemother; 2001 May; 45(5):1568-71. PubMed ID: 11302831
[TBL] [Abstract][Full Text] [Related]
3. Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori.
Sunairi M; Watanabe K; Suzuki T; Tanaka N; Kuwayama H; Nakajima M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S121-4. PubMed ID: 7735928
[TBL] [Abstract][Full Text] [Related]
4. In vitro anti-Helicobacter pylori activity of ebrotidine.
Palacín C; Tarragó C; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):471-4. PubMed ID: 9205746
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.
Dai G; Cheng N; Dong L; Muramatsu M; Xiao S; Wang MW; Zhu DX
Antimicrob Agents Chemother; 2005 Aug; 49(8):3468-73. PubMed ID: 16048962
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan.
Cheng A; Sheng WH; Liou JM; Wang HP; Wu MS; Lin JT; Chang SC
J Microbiol Immunol Infect; 2015 Feb; 48(1):72-9. PubMed ID: 23036269
[TBL] [Abstract][Full Text] [Related]
7. The post-antibiotic effects of rokitamycin (a 16-membered ring macrolide) on susceptible and erythromycin-resistant strains of Streptococcus pyogenes.
Braga PC; Culici M; Dal Sasso M
Int J Antimicrob Agents; 2004 Sep; 24(3):254-60. PubMed ID: 15325429
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the degree of susceptibility of Streptococcus pyogenes erythromycin-resistant strains to rokitamycin (a 16-membered macrolide) using the Epsilometer test.
Crotti D; Rossetti R; Braga PC
Drugs Exp Clin Res; 2004; 30(1):17-26. PubMed ID: 15134387
[TBL] [Abstract][Full Text] [Related]
9. Detection of rokitamycin-induced morphostructural alterations in Helicobacter pylori by atomic force microscopy.
Braga PC; Ricci D
Chemotherapy; 2000; 46(1):15-22. PubMed ID: 10601793
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic MICs and short time-killing against Helicobacter pylori: therapeutic potential of kanamycin.
Irie Y; Tateda K; Matsumoto T; Miyazaki S; Yamaguchi K
J Antimicrob Chemother; 1997 Aug; 40(2):235-40. PubMed ID: 9301989
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity of levofloxacin, gatifloxacin, penicillin, meropenem and rokitamycin against Bacillus anthracis clinical isolates.
Drago L; De Vecchi E; Lombardi A; Nicola L; Valli M; Gismondo MR
J Antimicrob Chemother; 2002 Dec; 50(6):1059-63. PubMed ID: 12461034
[TBL] [Abstract][Full Text] [Related]
12. [Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
Sugita K; Katouno Y; Uchida H; Kobayashi Y
Jpn J Antibiot; 2002 Dec; 55(6):771-7. PubMed ID: 12621731
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of rokitamycin, a new macrolide, against Borrelia burgdorferi.
Cinco M; Padovan D; Stinco G; Trevisan G
Antimicrob Agents Chemother; 1995 May; 39(5):1185-6. PubMed ID: 7625812
[TBL] [Abstract][Full Text] [Related]
14. Marked susceptibility of South African Helicobacter pylori strains to ciprofloxacin and amoxicillin: clinical implications.
Tanih NF; Okeleye BI; Naidoo N; Clarke AM; Mkwetshana N; Green E; Ndip LM; Ndip RN
S Afr Med J; 2010 Jan; 100(1):49-52. PubMed ID: 20429489
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo bactericidal activity of Tinospora sagittata (Oliv.) Gagnep. var. craveniana (S.Y.Hu) Lo and its main effective component, palmatine, against porcine Helicobacter pylori.
Rong Q; Xu M; Dong Q; Zhang Y; Li Y; Ye G; Zhao L
BMC Complement Altern Med; 2016 Aug; 16(1):331. PubMed ID: 27576439
[TBL] [Abstract][Full Text] [Related]
16. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.
Braga PC
J Chemother; 2002 Apr; 14(2):115-31. PubMed ID: 12017366
[TBL] [Abstract][Full Text] [Related]
17. Effects of rokitamycin and other macrolide antibiotics on Mycoplasma pneumoniae in L cells.
Misu T; Arai S; Furukawa M; Yamamoto Y; Miyazaki T
Antimicrob Agents Chemother; 1987 Nov; 31(11):1843-5. PubMed ID: 3124740
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey.
Caliskan R; Tokman HB; Erzin Y; Saribas S; Yuksel P; Bolek BK; Sevuk EO; Demirci M; Yılmazli O; Akgul O; Kalayci F; Cakan H; Salih B; Bal K; Kocazeybek B
Rev Soc Bras Med Trop; 2015; 48(3):278-84. PubMed ID: 26108005
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of minimal inhibitory concentration (MIC) and minimal lethal concentration (MLC) values for tetracycline, monocycline, erythromycin and rokitamycin against eleven strains of Chlamydia trachomatis].
Bianchi A; Scieux C; Robache S; Vassias I; Pérol Y
Pathol Biol (Paris); 1991 May; 39(5):442-5. PubMed ID: 1881673
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of rokitamycin compared with that of other macrolides.
Yu KW; Briones F; Chin NX; Neu HC
Diagn Microbiol Infect Dis; 1991; 14(4):331-5. PubMed ID: 1889182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
